This Congress is supported by educational grants from Bayer HealthCare Pharmaceuticals, Inc.; Celgene Corporation; Cephalon Oncology; Eisai Inc.; Genzyme; GlaxoSmithKline; Merck Oncology; Millennium: The Takeda Oncology Company; Novartis Oncology; and sanofi aventis U.S.
NCCN appreciates that these supporting companies recognize NCCN’s need for autonomy in the development of the content of NCCN programs and resources. All NCCN content is produced completely independently.
Privacy Policy| Legal Notices| Site Map| Contact Us| Help
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved